| TGA Action ID |
RC-2026-RN-00824-1 |
| Type of Product |
Medicine |
| Product Name/Description |
Cefazolin 6,000mg in 0.9% Sodium Chloride in Surefuser + for Intravenous Infusion
Batch Number: BB26101785
Expiry Date: 31/12/2026
ARTG Exempt |
| ARTG Number |
|
| Unique Device Identifier (UDI) |
BB260923447-IS5 |
| Action Type |
Product Alert |
| Action Level |
Hospital |
| Hazard Classification |
Class II |
| Reason for the Action |
Prior to patient treatment, the treating clinician noticed a product leak had occurred. The leak was contained within the clear inner protective packaging.
This product alert does not affect any other compounded batches of Cefazolin or any other Slade Health products.
Given the nature of the product, this action was undertaken prior to TGA notification (Immediate Market Action as defined within the PRAC). |
| Instructions for Customers/Users |
The product was discarded by the customer when the leak was identified.
Customers should inspect all remaining devices from this batch and dispose of any surefusers that may be affected. Unaffected stock can continue to be used. |
| Action Commencement Date |
15/10/2026 |
| Responsible Entity |
|
| Contact Information |
03 9565 4400 - Slade Health |